Dr. Beth Ann Staab, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-9116 |
Dr. Shelly Lea Larson-peters, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-9116 |
Dennis Taylor Jorgenson-rathke, PA-C Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 11091 Ulysses St Ne Ste 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0722 |
Tacjana Krystyna Eich Friday, MD Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St Ne Ste 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-9116 |
Ana P Groeschel, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses Street Ne, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0722 |
Chad D. Evans, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St Ne, Suite 100, Blaine, MN 55407 Phone: 612-879-1000 Fax: 612-879-0722 |
Robert G Jacoby, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses Street, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0782 |
Rebecca Lenore Ertsgaard, PA-C Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St Ne Ste 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0722 |
Deborah R Osgood, PA-C Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 11091 Ulysses St. Ne, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0722 |
Christine Ann Ebbers-furmanek, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 11091 Ulysses St Ne, Suite 100, Blaine, MN 55434 Phone: 612-879-1000 Fax: 612-879-0722 |
News Archive
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring the prevalence of antibodies against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among adults in England.
Copenhagen, Denmark: Higher than normal body mass index (BMI) is known to lead to cardiovascular ill-health in mid-to-late life, but there has been limited investigation of its effect in young, apparently healthy, adults.
› Verified 3 days ago